NCT03278782 2026-01-09Study of Pembrolizumab (MK-3475) in Combination With RomidepsinM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting39 enrolled
NCT02512497 2025-09-19Romidepsin Maintenance After Allogeneic Stem Cell TransplantationOhio State University Comprehensive Cancer CenterPhase 1 Completed23 enrolled